Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I3QX
|
|||
Drug Name |
Camrelizumab
|
|||
Synonyms |
GTPL9758; SHR-1210
Click to Show/Hide
|
|||
Drug Type |
Monoclonal antibody
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
Therapeutic Class |
Antiviral Agents
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | HUMAN programmed cell death protein 1 (PD-1) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04268537) Immunoregulatory Therapy for 2019-nCoV. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.